Janus Henderson Group
LXRX icon

Janus Henderson Group’s Lexicon Pharmaceuticals LXRX Stock Holding History

Janus Henderson Group’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-29,470
Closed -$32K – 2581
2023
Q3 		$32K Buy
29,470
+335
+1% +$588 ﹤0.01% 2555
2023
Q2 		$66.9K Buy
29,135
+505
+2% +$1.34K ﹤0.01% 2582
2023
Q1 		$69.4K Buy
28,630
+17,269
+152% +$39.6K ﹤0.01% 2642
2022
Q4 		$21.6K Sell
11,361
-11,361
-50% -$24.2K ﹤0.01% 2452
2022
Q3 		$54K Buy
22,722
+11,361
+100% +$31.4K ﹤0.01% 2517
2022
Q2 		$21K Sell
11,361
-454
-4% -$866 ﹤0.01% 2587
2022
Q1 		$25K Buy
11,815
+29
+0.2% +$80 ﹤0.01% 2633
2021
Q4 		$46K Buy
+11,786
New +$57.2K ﹤0.01% 2541

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $431B AUM 30.22% 1-Year Est. Return